Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.41%43.88M | 6.44%97.76M | -3.16%48.98M | 33.70%91.85M | 54.12%50.58M | 81.00%27.66M | -19.73%68.7M | -37.40%50.13M | -35.47%32.82M | -37.66%15.28M |
| Operating income | -10.41%43.88M | 6.44%97.76M | -3.16%48.98M | 33.70%91.85M | 54.12%50.58M | 81.00%27.66M | -19.73%68.7M | -37.40%50.13M | -35.47%32.82M | -37.66%15.28M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | 32.29%-7.78M | 34.89%-21.03M | 36.60%-11.49M | 16.85%-32.3M | -24.51%-18.12M | -39.40%-9.3M | -19.13%-38.84M | 14.65%-22.23M | 18.14%-14.55M | 24.72%-6.67M |
| Depreciation and amortization | 29.46%-4.39M | 12.50%-10.63M | 14.33%-6.22M | 2.43%-12.14M | -7.56%-7.26M | -6.42%-3.69M | 17.28%-12.45M | 15.26%-10.34M | 19.87%-6.75M | 17.65%-3.47M |
| Revaluation surplus | ---- | ---- | ---- | --13.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | --13.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | -2,296.71%-9.47M | ---- | ---395K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | -18.23%-467K | ---- | ---395K | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 1.89%-40.72M | -48.91%-76.63M | -24.33%-41.51M | 4.11%-51.46M | -18.10%-33.39M | -21.95%-17.61M | -62.99%-53.66M | -33.33%-40.73M | -98.10%-28.27M | -3,065.09%-14.44M |
| Operating profit | 12.01%-9M | -323.62%-19.99M | -24.99%-10.23M | 124.66%8.94M | 51.14%-8.18M | 68.39%-2.94M | -823.68%-36.25M | -305.53%-23.17M | -261.23%-16.75M | -177.95%-9.3M |
| Financing cost | 26.20%-462K | 13.15%-925K | -8.87%-626K | -34.64%-1.07M | -39.90%-575K | -38.42%-281K | 26.76%-791K | 75.58%-555K | 57.19%-411K | 39.76%-203K |
| Earning before tax | 12.83%-9.46M | -365.62%-20.91M | -23.93%-10.86M | 121.26%7.87M | 48.96%-8.76M | 66.11%-3.22M | -1,042.73%-37.04M | -363.59%-23.73M | -282.00%-17.16M | -181.97%-9.5M |
| Tax | 614.71%175K | -84.22%59K | 83.25%-34K | -84.51%374K | ---203K | ---202K | 2,553.85%2.42M | ---- | ---- | ---- |
| After-tax profit from continuing operations | 14.71%-9.29M | -352.86%-20.85M | -21.50%-10.89M | 123.82%8.25M | 47.78%-8.96M | 63.98%-3.42M | -961.32%-34.63M | -387.82%-23.73M | -283.54%-17.16M | -181.97%-9.5M |
| Earning after tax | 14.71%-9.29M | -352.86%-20.85M | -21.50%-10.89M | 123.82%8.25M | 47.78%-8.96M | 63.98%-3.42M | -961.32%-34.63M | -387.82%-23.73M | -283.54%-17.16M | -181.97%-9.5M |
| Profit attributable to shareholders | 14.71%-9.29M | -352.86%-20.85M | -21.50%-10.89M | 123.82%8.25M | 47.78%-8.96M | 63.98%-3.42M | -964.11%-34.63M | -388.49%-23.73M | -283.50%-17.16M | -181.94%-9.5M |
| Basic earnings per share | 31.58%-0.13 | -300.70%-0.3448 | -1,943.01%-0.19 | 575.90%0.1718 | 48.04%-0.0093 | 63.64%-0.0036 | -959.52%-0.0361 | -387.21%-0.0247 | -284.54%-0.0179 | -181.82%-0.0099 |
| Diluted earnings per share | 31.58%-0.13 | -306.22%-0.3448 | -1,943.01%-0.19 | 563.16%0.1672 | -0.0093 | -959.52%-0.0361 | ||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | Fan Chen Accounting Firm Limited | -- | -- | Fan Chen Certified Public Accountants Co., Ltd. | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.